Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. uri icon

authors

  • Sims, John R
  • Monkul Nery, Emel Serap
  • Collins, Emily C
  • Solomon, Paul
  • Salloway, Stephen
  • Liana Apostolova, MD, MSc, FAAN
  • Hansson, Oskar
  • Ritchie, Craig
  • Brooks, Dawn A
  • Mintun, Mark
  • Skovronsky, Daniel M
  • Zimmer, Jennifer A
  • Evans, Cynthia D
  • Lu, Ming
  • Ardayfio, Paul
  • Sparks, JonDavid
  • Wessels, Alette M
  • Shcherbinin, Sergey
  • Wang, Hong

publication date

  • August 8, 2023

published in